IBDEI0PZ ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34396,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,34396,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,34397,0)
 ;;=E89.0^^100^1499^50
 ;;^UTILITY(U,$J,358.3,34397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34397,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,34397,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,34397,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,34398,0)
 ;;=E03.2^^100^1499^32
 ;;^UTILITY(U,$J,358.3,34398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34398,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,34398,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,34398,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,34399,0)
 ;;=E03.9^^100^1499^33
 ;;^UTILITY(U,$J,358.3,34399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34399,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,34399,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,34399,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,34400,0)
 ;;=E06.0^^100^1499^53
 ;;^UTILITY(U,$J,358.3,34400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34400,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,34400,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,34400,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,34401,0)
 ;;=E06.1^^100^1499^54
 ;;^UTILITY(U,$J,358.3,34401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34401,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,34401,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,34401,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,34402,0)
 ;;=C73.^^100^1499^37
 ;;^UTILITY(U,$J,358.3,34402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34402,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,34402,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,34402,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,34403,0)
 ;;=E10.21^^100^1499^8
 ;;^UTILITY(U,$J,358.3,34403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34403,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,34403,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,34403,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,34404,0)
 ;;=E10.9^^100^1499^12
 ;;^UTILITY(U,$J,358.3,34404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34404,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,34404,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,34404,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,34405,0)
 ;;=E11.21^^100^1499^17
 ;;^UTILITY(U,$J,358.3,34405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34405,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,34405,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,34405,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,34406,0)
 ;;=E11.39^^100^1499^18
 ;;^UTILITY(U,$J,358.3,34406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34406,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,34406,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,34406,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,34407,0)
 ;;=E11.43^^100^1499^15
 ;;^UTILITY(U,$J,358.3,34407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34407,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,34407,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,34407,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,34408,0)
 ;;=E11.59^^100^1499^13
 ;;^UTILITY(U,$J,358.3,34408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34408,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,34408,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,34408,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,34409,0)
 ;;=E11.618^^100^1499^14
 ;;^UTILITY(U,$J,358.3,34409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34409,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,34409,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,34409,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,34410,0)
 ;;=E11.621^^100^1499^16
 ;;^UTILITY(U,$J,358.3,34410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34410,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,34410,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,34410,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,34411,0)
 ;;=E11.622^^100^1499^20
 ;;^UTILITY(U,$J,358.3,34411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34411,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,34411,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,34411,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,34412,0)
 ;;=E11.65^^100^1499^19
 ;;^UTILITY(U,$J,358.3,34412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34412,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,34412,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,34412,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,34413,0)
 ;;=E11.9^^100^1499^21
 ;;^UTILITY(U,$J,358.3,34413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34413,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,34413,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,34413,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,34414,0)
 ;;=E13.9^^100^1499^22
 ;;^UTILITY(U,$J,358.3,34414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34414,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,34414,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,34414,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,34415,0)
 ;;=E16.2^^100^1499^29
 ;;^UTILITY(U,$J,358.3,34415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34415,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,34415,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,34415,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,34416,0)
 ;;=E20.0^^100^1499^34
 ;;^UTILITY(U,$J,358.3,34416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34416,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,34416,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,34416,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,34417,0)
 ;;=E20.9^^100^1499^30
 ;;^UTILITY(U,$J,358.3,34417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34417,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,34417,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,34417,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,34418,0)
 ;;=E23.0^^100^1499^31
 ;;^UTILITY(U,$J,358.3,34418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34418,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,34418,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,34418,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,34419,0)
 ;;=E27.1^^100^1499^51
 ;;^UTILITY(U,$J,358.3,34419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34419,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,34419,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,34419,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,34420,0)
 ;;=E27.2^^100^1499^1
 ;;^UTILITY(U,$J,358.3,34420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34420,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,34420,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,34420,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,34421,0)
 ;;=E27.3^^100^1499^23
 ;;^UTILITY(U,$J,358.3,34421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34421,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,34421,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,34421,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,34422,0)
 ;;=E29.1^^100^1499^52
 ;;^UTILITY(U,$J,358.3,34422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34422,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,34422,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,34422,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,34423,0)
 ;;=E55.9^^100^1499^59
 ;;^UTILITY(U,$J,358.3,34423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34423,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,34423,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,34423,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,34424,0)
 ;;=E66.01^^100^1499^38
 ;;^UTILITY(U,$J,358.3,34424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34424,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,34424,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,34424,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,34425,0)
 ;;=E66.8^^100^1499^42
 ;;^UTILITY(U,$J,358.3,34425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34425,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,34425,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,34425,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,34426,0)
 ;;=E66.9^^100^1499^43
 ;;^UTILITY(U,$J,358.3,34426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34426,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,34426,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,34426,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,34427,0)
 ;;=E74.39^^100^1499^35
 ;;^UTILITY(U,$J,358.3,34427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34427,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,34427,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,34427,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,34428,0)
 ;;=E83.30^^100^1499^46
 ;;^UTILITY(U,$J,358.3,34428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34428,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,34428,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,34428,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,34429,0)
 ;;=E83.51^^100^1499^28
 ;;^UTILITY(U,$J,358.3,34429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34429,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,34429,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,34429,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,34430,0)
 ;;=E83.52^^100^1499^26
 ;;^UTILITY(U,$J,358.3,34430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34430,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,34430,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,34430,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,34431,0)
 ;;=E87.5^^100^1499^27
 ;;^UTILITY(U,$J,358.3,34431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34431,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,34431,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,34431,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,34432,0)
 ;;=E89.2^^100^1499^48
 ;;^UTILITY(U,$J,358.3,34432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34432,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,34432,1,4,0)
 ;;=4^E89.2
